Advertisement
Journal Home
Search for

Volume 44, Issue 1, Pages 8-11 (January 2008)


View previous. 4 of 25 View next.

Recommended changes to oncology clinical trial design: Revolution or evolution?

Mark J. RatainaCorresponding Author Informationemail address, Rachel W. Humphreyb, Gary B. Gordonc, Gwen Fyfed, Peter C. Adamsone, Thomas R. Flemingf, Walter M. Stadlera, Donald A. Berryg, Carl C. Peckh

Received 10 September 2007; accepted 19 September 2007. published online 05 November 2007.

No abstract is available. To read the body of this article, please view the Full Text online.

a University of Chicago, Chicago, IL, USA

b Bristol-Myers Squibb, Wallingford, CT, USA

c Abbott Laboratories, Abbott Park, IL, USA

d Genentech, San Francisco, CA, USA

e Children’s Hospital of Pennsylvania, Philadelphia, PA, USA

f University of Washington, Seattle, WA, USA

g MD Anderson Cancer Center, Houston, TX, USA

h University of California, San Francisco, CA, USA

Corresponding Author InformationCorresponding author: Tel.: +1 773 702 4400; fax: +1 773 702 3969.

PII: S0959-8049(07)00737-X

doi:10.1016/j.ejca.2007.09.011


View previous. 4 of 25 View next.